Decentralized Trials, Access, and Advancement with Craig Lipset

Join Craig Lipset, co-chair of the Decentralized Trials and Research Alliance and head of Innovation at the Buffalo Initiative, as we discuss decentralized trial methods and democratization of drug development. We cover access to knowledge, tools, and data widening the funnel for rare and ultra-rare disase drug development. We cover various approaches within the system, noting evidence for outcomes and data integrity. Lipset highlights oncology examples with FDA/ASCO as well.